AHFS Drug Information

8th April 2025

AHFS Drug Information

This update contains 9 new monographs and 44 revised monographs.

New monographs: Concizumab; Cosibelimab; Datopotamab Deruxtecan; Elagolix Sodium, Estradiol, and Norethindrone Acetate; Ensartinib Hydrochloride; Suzetrigine; Treosulfan; Vanzacaftor Calcium, Tezacaftor, and Deutivacaftor; Zenocutuzumab.

Revised monographs: Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl; Avacincaptad Pegol Sodium; Belumosudil Mesylate; Belzutifan; Brodalumab; cefTRIAXone Sodium; Certolizumab Pegol; Darunavir Ethanolate, Cobicistat, Emtricitabine, and Tenofovir Alafenamide Fumarate; Dolutegravir Sodium; Dolutegravir Sodium and Rilpivirine Hydrochloride; Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide Fumarate; Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate; Emtricitabine and Tenofovir Disoproxil Fumarate; Evolocumab; fentaNYL, fentaNYL Citrate; Fostemsavir Tromethamine; Glatiramer Acetate; Ibalizumab; Ibuprofen, Ibuprofen Lysine; lamiVUDine; Lonafarnib; Lopinavir and Ritonavir; Lurasidone Hydrochloride; Maraviroc; Methotrexate; Mirtazapine; Molnupiravir; Nabumetone; Nemolizumab; Pimavanserin Tartrate; Raltegravir Potassium; Remdesivir; Remifentanil Hydrochloride; Ribavirin; Sparsentan; Sulbactam Sodium and Durlobactam Sodium; Tazemetostat Hydrobromide; Teclistamab; Teduglutide; Tenofovir Alafenamide Fumarate; Tenofovir Disoproxil Fumarate; Toripalimab; Vilobelimab; Zidovudine.

11th March 2025

AHFS Drug Information

This update contains 4 new monographs, 38 revised monographs and 23 discontinued Monographs.

New monographs: Crinecerfont; Landiolol Hydrochloride; Olezarsen Sodium; Remestemcel-L-rknd.

Revised monographs: Abacavir Sulfate; Benzgalantamine Gluconate; Cabotegravir and Rilpivirine; Cabotegravir, Cabotegravir Sodium; Crisaborole; Dapagliflozin Propanediol; Darbepoetin Alfa; Deutetrabenazine; Dolutegravir Sodium and Lamivudine; Doravirine; Doravirine, Lamivudine, and Tenofovir Disoproxil Fumarate; DULoxetine Hydrochloride; Duvelisib; Eculizumab; Emtricitabine; Etravirine; Fezolinetant; Fosamprenavir Calcium; Guselkumab; Iloprost (Frostbite); Lazertinib Mesylate; Lonapegsomatropin-tcgd; Lotilaner; Macitentan and Tadalafil; Mavacamten; Metoclopramide Hydrochloride; Nelfinavir Mesylate; Nirmatrelvir and Ritonavir; Ravulizumab-cwvz; Respiratory Syncytial Virus Vaccine; Respiratory Syncytial Virus Vaccine, Adjuvanted; Ribociclib Succinate; Selpercatinib; Sparsentan; Tipranavir; Velmanase Alfa-tycv; Voclosporin; Zuranolone.

Discontinued monographs: Aducanumab; Antiretroviral General Statement; Bamlanivimab and etesevimab; Bebtelovimab; Belladonna; Casirivimab and imdevimab; Cefotaxime; Ceftobiprole; Copanlisib; HMG-CoA Reductase Inhibitors General Statement; Infigratinib; Insulin detemir; Olaratumab; Omacetaxine; Oprelvekin; Peginterferon alfa-2b; Rosiglitazone; Sodium phenylbutyrate and taurursodiol; Sotrovimab; Tixagevimab and cilgavimab; Vitamins A and D; Vorapaxar; Voxelotor.

11th February 2025

AHFS Drug Information

This update contains 6 new monographs and 21 revised monographs.

New monographs: Acoramidis Hydrochloride; Eladocagene Exuparvovec-tneq; Obecabtagene Autoleucel; Revumenib Citrate; Sulopenem etzadroxil and probenecid; Zanidatamab-hrii.

Revised monographs: Alpelisib; Aprocitentan; Aztreonam; Copyright and Notices; Empagliflozin; Ensifentrine; Epcoritamab-bysp; Furosemide; Iptacopan Hydrochloride; Ivacaftor; Ketamine Hydrochloride; Losartan Potassium; Obeticholic Acid; Omalizumab; Osimertinib Mesylate; Respiratory Syncytial Virus Vaccine (mRNA); Respiratory Syncytial Virus Vaccine; Respiratory Syncytial Virus Vaccine, Adjuvanted; Risankizumab-rzaa; Ustekinumab; Vericiguat.

14th January 2025

AHFS Drug Information

This update contains 4 new monographs and 13 revised monographs.

New monographs: Foscarbidopa and Foslevodopa; Inavolisib; Marstacimab-hncq;
Zolbetuximab-clzb.

Revised monographs: Aminocaproic Acid; Apalutamide; Apremilast; Cefiderocol; Celecoxib; Coagulation Factor Xa (Recombinant), Inactivated-zhzo (Systemic); Influenza Vaccine Inactivated; Lisinopril; Ponatinib; Ripretinib; Sarilumab; Tenapanor; Tocilizumab.

10th December 2024

AHFS Drug Information

This update contains 8 new monographs and 39 revised monographs.

New monographs: Arimoclomol Citrate; Artesunate; Azithromycin (EENT); Denileukin diftitox-cxdl; Deuruxolitinib Phosphate; Lebrikizumab-lbkz; Levacetylleucine; Xanomeline Tartrate and Trospium Chloride.

Revised monographs: Adagrasib; Adalimumab; Alectinib Hydrochloride; Benralizumab; Casimersen; Danicopan; Deflazacort; Dronabinol; Dupilumab; Edaravone; Eflornithine Hydrochloride; Enfuvirtide; Estrogen-Progestin Combinations; Etrasimod Arginine; Ixazomib Citrate; Ixekizumab; Lanreotide Acetate; Leniolisib Phosphate; Lidocaine Hydrochloride (Systemic); Lomustine; Midazolam, Midazolam Hydrochloride; Mirikizumab-mrkz; Nedosiran Sodium; Ozanimod Hydrochloride; Pirtobrutinib; Pozelimab-bbfg; Repotrectinib; Resmetirom; Riluzole; Sotatercept-csrk; Tepotinib Hydrochloride; Tisotumab vedotin-tftv; Tofersen; Tovorafenib; Tralokinumab-ldrm; Vadadustat; Vasopressin; Vedolizumab; Zanubrutinib.

12th November 2024

AHFS Drug Information